Neurotechnology currently is one of the most exciting areas of innovation at the intersection between medicine, digitalization and engineering. What still sounded like science fiction a mere couple of years ago has long since become reality in the…
EU project aims to make breakthrough in sustainable chemical manufacture
Early-stage and incorporated high-potential AI startups based in Germany can now apply for the next AI Nation Grant and the next AI Nation Accelerator batch.
Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries (BDI) recognize…
A combination of three drugs appears to more effectively treat people with cystic fibrosis than therapy with only two, concludes a study by Max Delbrück Center researchers published in “Cell Systems.” The study analyzed changes in the proteomes of…
Eckert & Ziegler SE (ISIN DE0005659700), a world-leading specialist in isotope-related components, equipment and services for nuclear medicine and radiation therapy, today signed a collaboration and supply agreement with Thor Medical, a leading…
Different types of bone marrow stem cells give rise to blood and immune cells. A team led by Simon Haas now reports in “Nature Cell Biology” how that diversity develops. The findings could help improve stem cell therapies, including treatments for…
Stiftung Charité is providing EUR 900,000 to support Charité’s new Profile Partnerships Program, part of the university hospital’s Internationalization Strategy 2030.
Lucid Genomics’ tertiary pipeline is validated for the interpretation of data generated using Oxford Nanopore sequencing.
Strategic Initiative Strengthens Berlin as Europe’s Hub of Digital Cardiology
